A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Quinidine barbiturate
Neratinib
The serum concentration of Ceritinib can be increased when it is combined with Neratinib.
Quinidine barbiturate
Velpatasvir
The serum concentration of Ceritinib can be increased when it is combined with Velpatasvir.
Quinidine barbiturate
Rolapitant
The serum concentration of Ceritinib can be increased when it is combined with Rolapitant.
Quinidine barbiturate
Daclatasvir
The serum concentration of Ceritinib can be increased when it is combined with Daclatasvir.
Quinidine barbiturate
Palbociclib
The serum concentration of Ceritinib can be increased when it is combined with Palbociclib.
Quinidine barbiturate
Brefeldin A
The serum concentration of Ceritinib can be increased when it is combined with Brefeldin A.
Quinidine barbiturate
Glasdegib
The serum concentration of Glasdegib can be increased when it is combined with Ceritinib.
Quinidine barbiturate
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be decreased when combined with Ceritinib.
Quinidine barbiturate
Isavuconazole
The serum concentration of Ceritinib can be increased when it is combined with Isavuconazole.
Quinidine barbiturate
Pitolisant
The serum concentration of Ceritinib can be decreased when it is combined with Pitolisant.
Quinidine barbiturate
Delamanid
Ceritinib may increase the QTc-prolonging activities of Delamanid.
Quinidine barbiturate
Apalutamide
The serum concentration of Ceritinib can be decreased when it is combined with Apalutamide.
Quinidine barbiturate
Relugolix
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ceritinib.
Quinidine barbiturate
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ceritinib.
Quinidine barbiturate
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Ceritinib.
Quinidine barbiturate
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Ceritinib.
Quinidine barbiturate
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Ceritinib.
Quinidine barbiturate
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Ceritinib.
Quinidine barbiturate
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Ceritinib.
Quinidine barbiturate
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Ceritinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3